Statements (30)
| Predicate | Object | 
|---|---|
| gptkbp:instanceOf | gptkb:brand gptkb:oral_contraceptive | 
| gptkbp:activeIngredient | gptkb:levonorgestrel gptkb:ethinyl_estradiol | 
| gptkbp:alternativeName | Alesse 21 Alesse 28 | 
| gptkbp:approvedBy | gptkb:FDA | 
| gptkbp:class | gptkb:oral_contraceptive | 
| gptkbp:contains | 0.02 mg ethinyl estradiol 0.1 mg levonorgestrel | 
| gptkbp:contraindication | gptkb:liver_disease history of thromboembolic disorders known or suspected pregnancy | 
| gptkbp:form | gptkb:tablet | 
| gptkbp:manufacturer | gptkb:Pfizer | 
| gptkbp:marketedIn | gptkb:Canada gptkb:United_States | 
| gptkbp:mechanismOfAction | inhibits ovulation alters endometrial lining thickens cervical mucus | 
| gptkbp:prescriptionStatus | prescription only | 
| gptkbp:routeOfAdministration | oral | 
| gptkbp:sideEffect | nausea headache breast tenderness irregular bleeding | 
| gptkbp:usedFor | birth control | 
| gptkbp:bfsParent | gptkb:ethinyl_estradiol | 
| gptkbp:bfsLayer | 8 | 
| https://www.w3.org/2000/01/rdf-schema#label | Alesse |